SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade
0:00
21:23
Dr. Briggs and Brendon Neuen discuss his paper in the December issue of JASN. This article on the CREDENCE and EMPA-CKD clinical trials shows that SGLT2 inhibitors allow more consistent use of RAS blockade in patients with declining renal function.
Flere episoder fra "Journal of the American Society of Nephrology (JASN)"
Gå ikke glip af nogen episoder af “Journal of the American Society of Nephrology (JASN)” - abonnér på podcasten med gratisapp GetPodcast.